Target intelligence / Profile preview

Various immune and hematopoietic cells (via cytokines, exosomes, and adhesion molecules)

Molecular classification
Cytokine, Adhesion molecule, Extracellular vesicle, Cell surface receptor
01

Overview

The phrase "Various immune and hematopoietic cells via cytokines, exosomes, and adhesion molecules" refers to the integrated network of communication that governs the development and function of the immune system [1]. This system relies on three primary modes of interaction: soluble signaling via cytokines, long-range or paracrine communication via exosomes, and direct cell-to-cell contact through adhesion molecules [2]. Cytokines, such as interleukins and interferons, act as the primary chemical messengers that dictate the activation, proliferation, and differentiation of immune cells [1]. Adhesion molecules, including integrins and selectins, are essential for the structural organization of lymphoid tissues and the recruitment of leukocytes to sites of inflammation [3]. Exosomes contribute to this network by transporting bioactive lipids, proteins, and RNAs between cells, thereby modulating the functional state of distant hematopoietic populations [2]. Dysregulation of these communication pathways is central to the pathogenesis of chronic inflammatory diseases, autoimmune disorders, and the progression of various cancers [4]. While the system as a whole is not a single drug target, many therapeutic agents are designed to intercept specific nodes within this network to restore homeostasis [3].

Other names
Immune-hematopoietic communication networkIntercellular signaling systemCytokine-exosome-adhesion axis
02

Mechanism of action

Modulation of intercellular communication through the inhibition or activation of specific cytokines, adhesion molecules, or cellular receptors within the hematopoietic and immune systems [1, 3].

03

Biological functions

Immune responseHematopoiesisCell-cell communicationCell migrationSignal transduction
04

Disease associations

InflammationCancerAutoimmune diseaseInfectionHematologic malignancy
05

Safety considerations

Systemic immunosuppressionCytokine release syndromeIncreased risk of infectionInfusion reactions
06

Interacting drugs

Infliximab

3 more in the full profile.

07

Biomarkers

Serum cytokine levels (e.g., IL-6, TNF-alpha)Cell surface marker expression (CD4, CD8, CD34)Exosomal cargo analysisC-reactive protein

Beyond the preview

Go deeper on Various immune and hematopoietic cells (via cytokines, exosomes, and adhesion molecules).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Various immune and hematopoietic cells (via cytokines, exosomes, and adhesion molecules).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call